BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Elmowafy AY, El Maghrabi HM, Eldahshan KF, Refaie AF, Elbasiony MA, Matter YE, Saleh HH, Shiha GE, Rostaing L, Bakr MA. Treatment of hepatitis C infection among Egyptian hemodialysis patients: the dream becomes a reality. Int Urol Nephrol 2019;51:1639-47. [PMID: 31363959 DOI: 10.1007/s11255-019-02246-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Chevallier E, Büchler M, Caillard S, Bouvier N, Colosio C, Rivalan J, Sayegh J, Bertrand D, Le Meur Y, Thierry A, Garrouste C, Rerolle JP, Rostaing L, Gatault P. Chronic Hepatitis C Virus Infection After Kidney Transplantation With or Without Direct-Acting Antivirals in a Real-Life Setting: A French Multicenter Experience. Transplant Proc 2020;52:3179-85. [PMID: 32636068 DOI: 10.1016/j.transproceed.2020.06.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Elmowafy AY, Abbas MH, Denewar AA, Mashaly ME, Shiha G, El Wasif SM, Rostaing L, Bakr MA. The effect of anemia on the efficacy and safety of treating chronic hepatitis C infection with direct-acting antivirals in patients with chronic kidney disease. Int Urol Nephrol 2021;53:749-61. [PMID: 33111161 DOI: 10.1007/s11255-020-02656-y] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Fabrizi F, Cerutti R, Messa P. Updated Evidence on the Epidemiology of Hepatitis C Virus in Hemodialysis. Pathogens 2021;10:1149. [PMID: 34578181 DOI: 10.3390/pathogens10091149] [Reference Citation Analysis]